Metabolic syndrome components increase endometrial cancer risk
A direct association exists between endometrial cancer risk and individual components of the metabolic syndrome beyond simply being overweight, according to a case-control study.
A direct association exists between endometrial cancer risk and individual components of the metabolic syndrome (MetS) beyond simply being overweight, according to a case-control study of more than 1,200 women in Italy.
Researchers found that women with type 2 diabetes mellitus were more than twice as likely as those without the disease to develop endometrial cancer (odds ratio [OR], 2.18).
In addition, the ORs for developing endometrial cancer were 1.77 for women with hypertension, 1.20 for women with hyperlipidemia, between 1.62 and 2.23 for women who fit various definitions of central obesity, and 3.83 for women with a body mass index (BMI) greater than 30 kg/m2.
Rosato V, Zucchetto A, Bosetti C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol. October 11, 2010. Epub ahead of print.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More
